Literature DB >> 11857419

Familial aggregation of urothelial cell carcinoma.

Katja K H Aben1, J Alfred Witjes, Mark P Schoenberg, Christina Hulsbergen-van de Kaa, André L M Verbeek, Lambertus A L M Kiemeney.   

Abstract

Urothelial cell carcinoma (UCC) is not considered to be a familial disease. Familial clustering of UCC was described in several case reports, however, some with an extremely early age at onset suggesting a genetic component. Epidemiological studies yielded inconsistent evidence of familial UCC, possibly because of low power and the inability to adjust for strong confounding. In our study the existence of a familial subtype of UCC was evaluated, as well as familial clustering of UCC with other types of cancer. A population-based family case-control study was performed including patients newly diagnosed with UCC of the bladder, ureter, renal pelvis or urethra, between January 1995 and December 1997, in the southeastern part of the Netherlands. Information on the patients' first-degree relatives was collected by postal questionnaire and subsequent telephone calls. The patients' partners filled out a similar questionnaire on their relatives. All reported occurrences of UCC were verified using medical records. Disease occurrence among case-relatives and control-relatives was compared to obtain the familial risk. Random effect proportional hazards regression analyses were used to calculate this familial risk while adjusting for age, gender and smoking behavior. In 95 families of the 1,193 patients and in 36 families of the 853 partners at least 1 relative was diagnosed with UCC. This yielded an adjusted hazard ratio (HR) of 1.8 (95% CI: 1.3-2.7). An increased risk was also found for cancer of the hematolymphopoietic system (hazard ration = 1.9, 95% CI: 1.2-3.1) among case-relatives. These results indicate that UCC has a familial component with an almost 2-fold increased risk among first-degree relatives of patients with UCC, which cannot be explained by smoking. Future segregation analyses may indicate whether this clustering can be attributed to genetic susceptibility. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11857419     DOI: 10.1002/ijc.10191

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  32 in total

1.  European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.

Authors:  Thorunn Rafnar; Sita H Vermeulen; Patrick Sulem; Gudmar Thorleifsson; Katja K Aben; J Alfred Witjes; Anne J Grotenhuis; Gerald W Verhaegh; Christina A Hulsbergen-van de Kaa; Soren Besenbacher; Daniel Gudbjartsson; Simon N Stacey; Julius Gudmundsson; Hrefna Johannsdottir; Hjordis Bjarnason; Carlo Zanon; Hafdis Helgadottir; Jon Gunnlaugur Jonasson; Laufey Tryggvadottir; Eirikur Jonsson; Gudmundur Geirsson; Sigfus Nikulasson; Vigdis Petursdottir; D Timothy Bishop; Sei Chung-Sak; Ananya Choudhury; Faye Elliott; Jennifer H Barrett; Margaret A Knowles; Petra J de Verdier; Charlotta Ryk; Annika Lindblom; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Paolo Vineis; Silvia Polidoro; Simonetta Guarrera; Carlotta Sacerdote; Angeles Panadero; José I Sanz-Velez; Manuel Sanchez; Gabriel Valdivia; Maria D Garcia-Prats; Jan G Hengstler; Silvia Selinski; Holger Gerullis; Daniel Ovsiannikov; Abdolaziz Khezri; Alireza Aminsharifi; Mahyar Malekzadeh; Leonard H van den Berg; Roel A Ophoff; Jan H Veldink; Maurice P Zeegers; Eliane Kellen; Jacopo Fostinelli; Daniele Andreoli; Cecilia Arici; Stefano Porru; Frank Buntinx; Abbas Ghaderi; Klaus Golka; José I Mayordomo; Giuseppe Matullo; Rajiv Kumar; Gunnar Steineck; Anne E Kiltie; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson; Lambertus A Kiemeney
Journal:  Hum Mol Genet       Date:  2011-07-12       Impact factor: 6.150

Review 2.  Vinflunine in the treatment of advanced urothelial cancer: clinical evidence and experience.

Authors:  Holger Gerullis; Friedhelm Wawroschek; Claus-Henning Köhne; Thorsten Holger Ecke
Journal:  Ther Adv Urol       Date:  2016-11-21

3.  A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

Authors:  Lambertus A Kiemeney; Patrick Sulem; Soren Besenbacher; Sita H Vermeulen; Asgeir Sigurdsson; Gudmar Thorleifsson; Daniel F Gudbjartsson; Simon N Stacey; Julius Gudmundsson; Carlo Zanon; Jelena Kostic; Gisli Masson; Hjordis Bjarnason; Stefan T Palsson; Oskar B Skarphedinsson; Sigurjon A Gudjonsson; J Alfred Witjes; Anne J Grotenhuis; Gerald W Verhaegh; D Timothy Bishop; Sei Chung Sak; Ananya Choudhury; Faye Elliott; Jennifer H Barrett; Carolyn D Hurst; Petra J de Verdier; Charlotta Ryk; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Paolo Vineis; Silvia Polidoro; Simonetta Guarrera; Carlotta Sacerdote; Marcello Campagna; Donatella Placidi; Cecilia Arici; Maurice P Zeegers; Eliane Kellen; Berta Saez Gutierrez; José I Sanz-Velez; Manuel Sanchez-Zalabardo; Gabriel Valdivia; Maria D Garcia-Prats; Jan G Hengstler; Meinolf Blaszkewicz; Holger Dietrich; Roel A Ophoff; Leonard H van den Berg; Kristin Alexiusdottir; Kristleifur Kristjansson; Gudmundur Geirsson; Sigfus Nikulasson; Vigdis Petursdottir; Augustine Kong; Thorgeir Thorgeirsson; N Aydin Mungan; Annika Lindblom; Michael A van Es; Stefano Porru; Frank Buntinx; Klaus Golka; José I Mayordomo; Rajiv Kumar; Giuseppe Matullo; Gunnar Steineck; Anne E Kiltie; Katja K H Aben; Eirikur Jonsson; Unnur Thorsteinsdottir; Margaret A Knowles; Thorunn Rafnar; Kari Stefansson
Journal:  Nat Genet       Date:  2010-03-28       Impact factor: 38.330

4.  Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population.

Authors:  Koichi Matsuda; Atsushi Takahashi; Candace D Middlebrooks; Wataru Obara; Yasutomo Nasu; Keiji Inoue; Kenji Tamura; Ichiro Yamasaki; Yoshio Naya; Chizu Tanikawa; Ri Cui; Jonine D Figueroa; Debra T Silverman; Nathaniel Rothman; Mikio Namiki; Yoshihiko Tomita; Hiroyuki Nishiyama; Kenjiro Kohri; Takashi Deguchi; Masayuki Nakagawa; Masayoshi Yokoyama; Tsuneharu Miki; Hiromi Kumon; Tomoaki Fujioka; Ludmila Prokunina-Olsson; Michiaki Kubo; Yusuke Nakamura; Taro Shuin
Journal:  Hum Mol Genet       Date:  2014-10-03       Impact factor: 6.150

5.  Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours.

Authors:  David R Yates; Morgan Rouprêt; Sarah J Drouin; Marie Audouin; Géraldine Cancel-Tassin; Eva Comperat; Marc-Olivier Bitker; Olivier Cussenot
Journal:  World J Urol       Date:  2012-09-28       Impact factor: 4.226

6.  Genetic susceptibility to bladder cancer risk and outcome.

Authors:  Jian Gu; Xifeng Wu
Journal:  Per Med       Date:  2011-05       Impact factor: 2.512

Review 7.  Contemporary management of low-risk bladder cancer.

Authors:  Johannes Falke; J Alfred Witjes
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

Review 8.  Familial and genetic risk of transitional cell carcinoma of the urinary tract.

Authors:  Christine M Mueller; Neil Caporaso; Mark H Greene
Journal:  Urol Oncol       Date:  2008-06-18       Impact factor: 3.498

9.  Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk.

Authors:  Meng Chen; Adrian Cassidy; Jian Gu; George L Delclos; Fan Zhen; Hushan Yang; Michelle A T Hildebrandt; Jie Lin; Yuanqing Ye; Robert M Chamberlain; Colin P Dinney; Xifeng Wu
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

10.  Sequence variant on 8q24 confers susceptibility to urinary bladder cancer.

Authors:  Lambertus A Kiemeney; Steinunn Thorlacius; Patrick Sulem; Frank Geller; Katja K H Aben; Simon N Stacey; Julius Gudmundsson; Margret Jakobsdottir; Jon T Bergthorsson; Asgeir Sigurdsson; Thorarinn Blondal; J Alfred Witjes; Sita H Vermeulen; Christina A Hulsbergen-van de Kaa; Dorine W Swinkels; Martine Ploeg; Erik B Cornel; Henk Vergunst; Thorgeir E Thorgeirsson; Daniel Gudbjartsson; Sigurjon A Gudjonsson; Gudmar Thorleifsson; Kari T Kristinsson; Magali Mouy; Steinunn Snorradottir; Donatella Placidi; Marcello Campagna; Cecilia Arici; Kvetoslava Koppova; Eugene Gurzau; Peter Rudnai; Eliane Kellen; Silvia Polidoro; Simonetta Guarrera; Carlotta Sacerdote; Manuel Sanchez; Berta Saez; Gabriel Valdivia; Charlotta Ryk; Petra de Verdier; Annika Lindblom; Klaus Golka; D Timothy Bishop; Margaret A Knowles; Sigfus Nikulasson; Vigdis Petursdottir; Eirikur Jonsson; Gudmundur Geirsson; Baldvin Kristjansson; Jose I Mayordomo; Gunnar Steineck; Stefano Porru; Frank Buntinx; Maurice P Zeegers; Tony Fletcher; Rajiv Kumar; Giuseppe Matullo; Paolo Vineis; Anne E Kiltie; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Thorunn Rafnar; Kari Stefansson
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.